Table of Contents
Journal of Neurodegenerative Diseases
Volume 2013 (2013), Article ID 903875, 7 pages
http://dx.doi.org/10.1155/2013/903875
Clinical Study

Clinical and Genetic Study of Algerian Patients with Spinal Muscular Atrophy

1Service of Neurology CHU of Constantine, Algeria
2Laboratory of Biology and Molecular Genetics CHU and University of Constantine, Algeria
3Laboratory of Biochemistry CHU of Constantine, Algeria
4Service of Pediatrics CHU de Constantine, Algeria
5Genetic Department of the Necker Hospital and Paris Descartes University, Paris, France

Received 20 December 2012; Revised 12 February 2013; Accepted 18 February 2013

Academic Editor: Haluk Topaloglu

Copyright © 2013 Y. Sifi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Dubowitz, “Muscle disorders in childhood,” Major Problems in Clinical Pediatrics, vol. 16, pp. 1–282, 1978. View at Google Scholar · View at Scopus
  2. A. Czeizel and J. Hamula, “A Hungarian study on Werdnig-Hoffmann disease,” Journal of Medical Genetics, vol. 26, no. 12, pp. 761–763, 1989. View at Google Scholar · View at Scopus
  3. J. Pearn, “Classification of spinal muscular atrophies,” The Lancet, vol. 1, no. 8174, pp. 919–922, 1980. View at Google Scholar · View at Scopus
  4. I. Biros and S. Forrest, “Spinal muscular atrophy: untangling the knot?” Journal of Medical Genetics, vol. 36, no. 1, pp. 1–8, 1999. View at Google Scholar · View at Scopus
  5. T. C. Gilliam, L. M. Brzustowicz, L. H. Castilla et al., “Genetic homogeneity between acute and chronic forms of spinal muscular atrophy,” Nature, vol. 345, no. 6278, pp. 823–825, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Melki, S. Abdelhak, P. Sheth et al., “Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q,” Nature, vol. 344, no. 6268, pp. 767–768, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. T. L. Munsat, L. Skerry, B. Korf et al., “Phenotypic heterogeneity of spinal muscular atrophy mapping to chromosome 5q11.2-13.3 (SMA 5q),” Neurology, vol. 40, no. 12, pp. 1831–1836, 1990. View at Google Scholar · View at Scopus
  8. S. Lefebvre, L. Bürglen, S. Reboullet et al., “Identification and characterization of a spinal muscular atrophy-determining gene,” Cell, vol. 80, no. 1, pp. 155–165, 1995. View at Google Scholar · View at Scopus
  9. U. R. Monani, C. L. Lorson, D. W. Parsons et al., “A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2,” Human Molecular Genetics, vol. 8, no. 7, pp. 1177–1183, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Bürglen, S. Lefebvre, O. Clermont et al., “Structure and organization of the human survival motor neurone (SMN) gene,” Genomics, vol. 32, no. 3, pp. 479–482, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Scheffer, J. M. Cobben, G. Matthijs, and B. Wirth, “Best practice guidelines for molecular analysis in spinal muscular atrophy,” European Journal of Human Genetics, vol. 9, no. 7, pp. 484–491, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Burlet, L. Bürglen, O. Clermont et al., “Large scale deletions of the 5q13 region are specific to Werdnig-Hoffmann disease,” Journal of Medical Genetics, vol. 33, no. 4, pp. 281–283, 1996. View at Google Scholar · View at Scopus
  13. F. Capon, C. Levato, S. Semprini et al., “Deletion analysis of SMN and NAIP gene in spinal muscular atrophy Italian families,” Muscle & Nerve, vol. 19, pp. 378–380, 1996. View at Google Scholar
  14. D. W. Parsons, P. E. McAndrew, S. T. Iannaccone, J. R. Mendell, A. H. M. Burghes, and T. W. Prior, “Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number,” American Journal of Human Genetics, vol. 63, no. 6, pp. 1712–1723, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Wirth, “An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA),” Human Mutation, vol. 15, pp. 228–237, 2000. View at Google Scholar
  16. S. Srivastava, M. Mukherjee, I. Panigrahi, G. S. Pandey, S. Pradhan, and B. Mittal, “SMN2-deletion in childhood-onset spinal muscular atrophy,” American Journal of Medical Genetics, vol. 101, no. 3, pp. 198–202, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. J. E. Taylor, N. H. Thomas, C. M. Lewis et al., “Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy,” European Journal of Human Genetics, vol. 6, no. 5, pp. 467–474, 1998. View at Google Scholar · View at Scopus
  18. M. Gennarelli, M. Lucarelli, F. Capon et al., “Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients,” Biochemical and Biophysical Research Communications, vol. 213, no. 1, pp. 342–348, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Helmken, Y. Hofmann, F. Schoenen et al., “Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1,” Human Genetics, vol. 114, no. 1, pp. 11–21, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Roy, M. S. Mahadevan, M. McLean et al., “The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy,” Cell, vol. 80, no. 1, pp. 167–178, 1995. View at Google Scholar · View at Scopus
  21. M. J. Somerville, A. G. Hunter, H. L. Aubry, R. G. Korneluk, A. E. MacKenzie, and L. C. Surh, “Clinical application of the molecular diagnosis of spinal muscular atrophy: deletions of neuronal apoptosis inhibitor protein and survival motor neuron genes,” American Journal of Medical Genetics, vol. 69, pp. 159–165, 1997. View at Google Scholar
  22. L. Campbell, A. Potter, J. Ignatius, V. Dubowitz, and K. Davies, “Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype,” American Journal of Human Genetics, vol. 61, no. 1, pp. 40–50, 1997. View at Google Scholar · View at Scopus
  23. J. G. Chang, Y. J. Jong, J. M. Huang et al., “Molecular basis of spinal muscular atrophy in Chinese,” American Journal of Human Genetics, vol. 57, no. 6, pp. 1503–1505, 1995. View at Google Scholar · View at Scopus
  24. N. R. Rodrigues, N. Owen, K. Talbot, J. Ignatius, V. Dubswitz, and K. E. Davies, “Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy,” Human Molecular Genetics, vol. 4, no. 4, pp. 631–634, 1995. View at Google Scholar · View at Scopus
  25. E. Velasco, C. Valero, A. Valero, F. Moreno, and C. Hernández-Chico, “Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of (C)BCD541 and SMA phenotype,” Human Molecular Genetics, vol. 5, pp. 257–263, 1996. View at Google Scholar
  26. T. L. Munsat, “International SMA collaboration,” Neuromuscular Disorders, vol. 1, no. 2, p. 81, 1991. View at Google Scholar · View at Scopus
  27. K. Zerres, S. Rudnik-Schöneborn, E. Forrest, A. Lusakowska, J. Borkowska, and I. Hausmanowa-Petrusewicz, “A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients,” Journal of the Neurological Sciences, vol. 146, no. 1, pp. 69–72, 1997. View at Google Scholar · View at Scopus
  28. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, p. 1215, 1988. View at Publisher · View at Google Scholar · View at Scopus
  29. G. van der Steege, P. M. Grootscholten, P. van der Vlies et al., “PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy,” The Lancet, vol. 345, no. 8955, pp. 985–986, 1995. View at Google Scholar · View at Scopus
  30. B. Wirth, T. Schmidt, E. Hahnen et al., “De novo rearrangements found in 2% index patients with spinal muscular atrophy (SMA): mutational mechanisms, parental origin, mutation rate and implications for prenatal diagnosis,” The American Journal of Human Genetics, vol. 61, pp. 1102–1111, 1997. View at Publisher · View at Google Scholar
  31. B. Wirth, M. Herz, A. Wetter et al., “Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype- phenotype correlation, and implications for genetic counseling,” American Journal of Human Genetics, vol. 64, no. 5, pp. 1340–1356, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Zerres and S. Rudnik-Schöneborn, “Natural history in proximal spinal muscular atrophy: clinical analysis of 445 patients and suggestions for a modification of existing classifications,” Archives of Neurology, vol. 52, no. 5, pp. 518–523, 1995. View at Google Scholar · View at Scopus
  33. C. A. Kim, B. Passos, and A. Marie, “Clinical and molecular analysis of spinal muscular atrophy in Brasilian patients,” Genetics and Molecular Biology, vol. 22, no. 4, pp. 1415–4757, 1999. View at Google Scholar
  34. A. Belaid, “Amyotrophies Spinales,” sous la direction de Cecile Jeager-Buet, Collection savoir et comprendre. AFM, 28, Juin 2006.
  35. S. Rudnik-Schöneborn, D. Rohrig, G. Morgan, B. Wirth, and K. Zerres, “Autosomal recessive proximal spinal muscular atrophy in 101 sibs out of 48 families: clinical picture, influence of gender, and genetic implications,” American Journal of Medical Genetics, vol. 51, no. 1, pp. 70–76, 1994. View at Google Scholar · View at Scopus
  36. M. Tazir and C. Geronimi, “Chronic childhood spinal muscular atrophies in Algeria. A genetic study,” Journal of the Neurological Sciences, vol. 96, no. 1, pp. 89–101, 1990. View at Publisher · View at Google Scholar · View at Scopus
  37. Enquête sur la consanguinité en Algérie, “Fondation nationale pour la promotion de la sante et le développement de la recherche (FOREM),” Septembre 2007.
  38. K. Cho, K. Ryu, E. Lee et al., “Correlation between genotype and phenotype in Korean patients with spinal muscular atrophy,” Molecules and Cells, vol. 11, no. 1, pp. 21–27, 2001. View at Google Scholar · View at Scopus
  39. N. Duc Bach, A. Hamim Sadewa, Y. Takeshima et al., “Deletion of the SMN1 and NAIP genes in Vietnamese patients with spinal muscular atrophy,” Kobe Journal of Medical Sciences, vol. 49, no. 3-4, pp. 55–58, 2003. View at Google Scholar · View at Scopus
  40. R. Labrum, J. Rodda, and A. Krause, “The molecular basis of Spinal Muscular Atrophy (SMA) in South African black patients,” Neuromuscular Disorders, vol. 17, no. 9-10, pp. 684–692, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. R. M. Shawky, K. Abd El Aleem, M. M. Rifaat, and A. Moustafa, “Molecular diagnosis of spinal muscular atrophy in Egyptians,” Eastern Mediterranean Health Journal, vol. 7, no. 1-2, pp. 229–237, 2001. View at Google Scholar · View at Scopus
  42. A. S. Glotov, A. V. Kiselev, T. E. Ivaschenko, and V. S. Baranov, “Analysis of deletions in SMN1, SMN2, and NAIP genes in spinal muscular atrophy patients from the northwestern region of Russia,” Russian Journal of Genetics, vol. 37, no. 8, pp. 968–971, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Kesari, U. K. Misra, J. Kalita et al., “Study of survival of motor neuron (SMN) and neuronal apoptosis inhibitory protein (NAIP) gene deletions in SMA patients,” Journal of Neurology, vol. 252, no. 6, pp. 667–671, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Al Rajeh, A. Ramanath Majumdar, A. Adetunji Adeyokunnu et al., “Molecular analysis of the SMN and NAIP genes in Saudi spinal muscular atrophy patients,” Journal of the Neurological Sciences, vol. 158, no. 1, pp. 43–46, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. N. R. Rodrigues, N. Owen, K. Talbot et al., “Gene deletions in spinal muscular atrophy,” Journal of Medical Genetics, vol. 33, no. 2, pp. 93–96, 1996. View at Google Scholar · View at Scopus
  46. M. S. Watihayati, A. M. H. Zabidi-Hussin, T. H. Tang, H. Nishio, and B. A. Zilfalil, “NAIP-deletion analysis in Malaysian patients with spinal muscular atrophy,” Kobe Journal of Medical Sciences, vol. 53, no. 4, pp. 171–175, 2007. View at Google Scholar · View at Scopus
  47. A. Amara, L. Adala, I. Ben Charfeddine et al., “Correlation of SMN2, NAIP, p44, H4F5 and Occludin genes copy number with spinal muscular atrophy phenotype in Tunisian patients,” European Journal of Paediatric Neurology, vol. 16, no. 2, pp. 167–174, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. D. D. Coovert, T. T. Le, P. E. McAndrew et al., “The survival motor neuron protein in spinal muscular atrophy,” Human Molecular Genetics, vol. 6, no. 8, pp. 1205–1214, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Humphrey, H. R. Fuller, and G. E. Morris, “Current research on SMN protein and treatment strategies for spinal muscular atrophy,” Neuromuscular Disorders, vol. 22, no. 2, pp. 193–197, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Lefebvre, P. Burlet, Q. Liu et al., “Correlation between severity and SMN protein level in spinal muscular atrophy,” Nature Genetics, vol. 16, no. 3, pp. 265–269, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Feldkötter, V. Schwarzer, R. Wirth, T. F. Wienker, and B. Wirth, “Quantitative analyses of SMN1 and SMN2 based on real-time lightcycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy,” American Journal of Human Genetics, vol. 70, no. 2, pp. 358–368, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. M. D. Mailman, J. W. Heinz, A. C. Papp et al., “Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2,” Genetics in Medicine, vol. 4, no. 1, pp. 20–26, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Ogino, S. Gao, D. G. Leonard, M. Paessler, and R. B. Wilson, “Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1,” European Journal of Human Genetics, vol. 11, no. 3, pp. 275–277, 2003. View at Google Scholar · View at Scopus
  54. B. Wirth, L. Brichta, B. Schrank et al., “Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number,” Human Genetics, vol. 119, no. 4, pp. 422–428, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Bouhouche, A. Benomar, N. Birouk et al., “High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients,” Journal of Neurology, vol. 250, no. 10, pp. 1209–1213, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Savas, N. Gokgoz, H. Kayserili, F. Ozkinay, M. Yuksel-Apak, and B. Kirdar, “Screening of deletions in SMN, NAIP and BTF2p44 genes in Turkish spinal muscular atrophy patients,” Human Heredity, vol. 50, no. 3, pp. 162–165, 2000. View at Google Scholar · View at Scopus
  57. B. Wirth, E. Hahnen, K. Morgan et al., “Allelic association and deletions in autosomal recessive proximal spinal muscular atrophy: association of marker genotype with disease severity and candidate cDNAs,” Human Molecular Genetics, vol. 4, no. 8, pp. 1273–1284, 1995. View at Google Scholar · View at Scopus
  58. E. Bussaglia, O. Clermont, E. Tizzano et al., “A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients,” Nature Genetics, vol. 11, no. 3, pp. 335–337, 1995. View at Google Scholar · View at Scopus
  59. J. M. Cobben, G. van der Steege, P. Grootscholten, M. de Visser, H. Scheffer, and C. H. C. M. Buys, “Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy,” American Journal of Human Genetics, vol. 57, no. 4, pp. 805–808, 1995. View at Google Scholar · View at Scopus
  60. T. Akutsu, H. Nishio, K. Sumino et al., “Molecular genetics of spinal muscular atrophy: contribution of the NAIP gene to clinical severity,” Kobe Journal of Medical Sciences, vol. 48, no. 1-2, pp. 25–31, 2002. View at Google Scholar · View at Scopus
  61. R. M'rad, I. Dorboz, L. B. Jemaa et al., “Molecular analysis of the SMN1 and naip genes in 60 Tunisian spinal muscular atrophy patients,” La Tunisie Medicale, vol. 84, no. 8, pp. 465–469, 2006. View at Google Scholar · View at Scopus
  62. Y. Shafeghati, S. Teymourian, G. Babamohammadi et al., “Molecular diagnosis Iranian patients with spinal muscular atrophy,” Archives of Iranian Medicine, vol. 7, no. 1, pp. 47–52, 2004. View at Google Scholar · View at Scopus
  63. M. Z. Haider, A. Moosa, H. Dalal, Y. Habib, and L. Reynold, “Gene deletion patterns in spinal muscular atrophy patients with different clinical phenotypes,” Journal of Biomedical Science, vol. 8, no. 2, pp. 191–196, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. C. H. Tsai, Y. J. Jong, C. J. Hu et al., “Molecular analysis of SMN, NAIP and P44 genes of SMA patients and their families,” Journal of the Neurological Sciences, vol. 190, no. 1-2, pp. 35–40, 2001. View at Google Scholar · View at Scopus